SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending following a strong quarterly earnings report that featured a massive revenue backlog, signaling sustained, aggressive demand for AI infrastructure despite ongoing net losses. Community sentiment is sharply divided between bulls highlighting the company's rapid capacity expansion and order book growth, and bears expressing concerns over high debt levels and negative cash flow.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as investors focus on the company's strategic pivot toward AI infrastructure following its acquisition of Northern Data, a move that has significantly expanded its GPU capacity and data center footprint. The community is actively debating the potential for a massive short squeeze due to record-high short interest, while simultaneously analyzing the upcoming earnings report and formal guidance as key catalysts for a long-term re-rating.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum is trending following an exceptionally strong quarterly earnings report that featured a revenue beat and robust forward guidance, confirming that AI-driven demand for ultra-high-power lasers and optical connectivity continues to significantly outpace supply. Investors and the community are actively debating the stock's potential for further upside as the optics sector increasingly becomes viewed as a critical infrastructure bottleneck, with many pointing to the company's strong backlog and favorable long-term growth prospects.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is currently facing significant selling pressure amid a broader retail sector downturn and ongoing concerns regarding the company's turnaround strategy in China. Investors are actively debating whether the stock is a deep-value opportunity at current levels or a long-term 'value trap' as management continues to navigate market share competition and margin headwinds.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is experiencing a significant surge in investor attention following reports that it is scaling manufacturing capacity to meet growing demand from aerospace and defense sectors. The community is actively discussing the stock's potential for a short squeeze due to high short interest and institutional accumulation, while some investors remain focused on the company's long-term integration into critical supply chains.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Trulieve Cannabis Corp is trending as investors react to its historic NYSE listing and the commencement of a share buyback program, despite recent price volatility and the surprise resignation of the company president. The community remains focused on the company's long-term potential following medical marijuana rescheduling while actively debating whether recent price dips represent a buying opportunity or a signal of broader sector manipulation.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as investors monitor the company's progress toward commercializing its optical interposer technology amidst a broader surge in AI infrastructure and photonics demand. Market attention is currently hyper-focused on the company's anticipated quarterly earnings and the execution of its production ramp, with community discussions heavily weighing recent developments from key partners like Lumilens.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging after hours as investors react to a significant earnings beat and aggressive fiscal 2027 revenue guidance that smashed analyst expectations, signaling continued strength in AI infrastructure demand. While the community is debating potential legal headwinds and past volatility, many are focused on the company's decision to suspend its ATM offering and the record backlog that could trigger a major short squeeze.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is facing significant volatility following a major downward revision to revenue guidance and a weak earnings report that disappointed investors, fueling ongoing community debates about management's execution. While some shareholders remain bullish on the long-term strategic value of the company's domestic antimony production for national security, others are actively discussing concerns over supply chain pricing, the lack of transparency, and the stock's recent performance relative to broader market movers.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is rallying following positive topline Phase 3 data for its DT120 depression treatment, which showed robust and durable efficacy with a clean safety profile. The community is actively discussing the stock's future potential, particularly the upcoming Phase 3 anxiety readout, while many long-term investors are expressing relief after years of holding.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$COYA $XBI $BMY 
Post the approval, we believe there is a high probability for approval of Dr Reddy&#39;s Abatacept in the near term.

https://www.businesstoday.in/markets/stocks/story/dr-reddys-shares-nuvama-sees-abatacept-approval-semaglutide-relaunch-as-key-triggers-check-target-price-546764-2026-08-03

Kyle Stevens

Bach abdel

Darryl Mulder

Investor One

The domestic brokerage said the recent US Food and Drug Administration (USFDA) approval for rituximab is a positive development as the drug was filed from Dr Reddy's Bachupally biologics facility.

Business Today

Dr Reddy's shares: Nuvama sees Abatacept approval, semaglutide relaunch as key triggers; retains 'Buy' - BusinessToday

StockTwits For Android 

Coya Therapeutics Inc

SPDR S&P Biotech ETF

Bristol-Myers Squibb Co.

 
Post the approval, we believe there is a high probability for approval of Dr Reddy's Abatacept in the near term.

